Dr. Seth Bilazarian discusses a recent paper published in Circulation by Drs. Benedikt Schrage, Karim Ibrahim, et. al. on a retrospective matched-pair analysis comparing patients in cardiogenic shock treated with balloon pump and Impella. Dr. Bilazarian highlights several limitations of the analysis, which used a matched-pair analysis to “harmonize baseline characteristics” of Impella-treated patients with … Continue reading “Dr. Seth Bilazarian on the recent Circulation paper by Dr. Schrage/Dr. Ibrahim”
Tag: Dr. Seth Bilazarian
New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Specialist Opinion with Dr. Seth Bilazarian A new retrospective, single-center study published in Circulation Research finds use of hemodynamic support with Impella 2.5® heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) even when those patients had preexisting kidney disease and low ejection fraction (EF). The new … Continue reading “New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention”
Day 2 of the ACC 2016 Scientific Session and Expo in Chicago – watch as Abiomed’s VP of Interventional Cardiology Programs, Dr. Seth Bilazarian, discusses some highlights.
Today the ACC 2016 Scientific Session and Expo kicked off in Chicago. Watch as Abiomed’s VP of Interventional Cardiology Programs, Dr. Seth Bilazarian, discusses some Day 1 highlights.